(Q44309116)

1 December 2017

In vitro and in vivo efficacy of YTR-830H and piperacillin combinations versus beta-lactamase-producing bacteria (English)

1 reference

1 December 2017

Kuck NA

1

1 reference

1 December 2017

Petersen PJ

series ordinal

2

1 reference

1 December 2017

Weiss WJ

series ordinal

3

1 reference

1 December 2017

Testa RT

series ordinal

4

1 reference

1 December 2017

language of work or name

1 reference

1 June 1989

1 reference

1 December 2017

Journal of Chemotherapy

1 reference

1 December 2017

1

1 reference

1 December 2017

3

1 reference

1 December 2017

155-161

1 reference

Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases

1 December 2017

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738884

Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738884

Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738884

Synergy of amoxycillin combined with clavulanate and YTR 830 in experimental infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738884

Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738884

10.1080/1120009X.1989.11738884

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference